BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31689135)

  • 1. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts.
    Cáceres FT; Gaspari TA; Samuel CS; Pinar AA
    FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors.
    Tapia Cáceres F; Gaspari TA; Hossain MA; Samuel CS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1.
    Pinar AA; Yuferov A; Gaspari TA; Samuel CS
    Front Pharmacol; 2020; 11():1201. PubMed ID: 32848798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis.
    Pan XC; Liu Y; Cen YY; Xiong YL; Li JM; Ding YY; Tong YF; Liu T; Chen XH; Zhang HG
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.
    Sassoli C; Chellini F; Pini A; Tani A; Nistri S; Nosi D; Zecchi-Orlandini S; Bani D; Formigli L
    PLoS One; 2013; 8(5):e63896. PubMed ID: 23704950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
    Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
    FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
    Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
    Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation.
    Wang Y; Wu Y; Chen J; Zhao S; Li H
    Cardiology; 2013; 126(1):1-11. PubMed ID: 23839341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of relaxin on cardiac fibroblast-to-myofibroblast transition: an electrophysiological study.
    Squecco R; Sassoli C; Garella R; Chellini F; Idrizaj E; Nistri S; Formigli L; Bani D; Francini F
    Exp Physiol; 2015 Jun; 100(6):652-66. PubMed ID: 25786395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome.
    Bracey NA; Gershkovich B; Chun J; Vilaysane A; Meijndert HC; Wright JR; Fedak PW; Beck PL; Muruve DA; Duff HJ
    J Biol Chem; 2014 Jul; 289(28):19571-84. PubMed ID: 24841199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose.
    Zhang X; Fu Y; Li H; Shen L; Chang Q; Pan L; Hong S; Yin X
    J Cell Mol Med; 2018 Mar; 22(3):1816-1825. PubMed ID: 29314607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diesel Exhaust Particulates Enhances Susceptibility of LPS-Induced Acute Lung Injury through Upregulation of the IL-17 Cytokine-Derived TGF-β
    Kim DI; Song MK; Lee K
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33419073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
    You Y; Huang Y; Wang D; Li Y; Wang G; Jin S; Zhu X; Wu B; Du X; Li X
    J Cell Physiol; 2019 Apr; 234(4):4668-4680. PubMed ID: 30246378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
    Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
    Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon nanotubes and crystalline silica stimulate robust ROS production, inflammasome activation, and IL-1β secretion in macrophages to induce myofibroblast transformation.
    Hindman B; Ma Q
    Arch Toxicol; 2019 Apr; 93(4):887-907. PubMed ID: 30847537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Gan W; Ren J; Li T; Lv S; Li C; Liu Z; Yang M
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):1-10. PubMed ID: 28986310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.